These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effects of U-50 488H, a kappa-agonist, on action potentials of isolated ventricular papillary muscle of guinea pigs.
    Author: Sheng JZ, Dong H, Wong TM.
    Journal: Zhongguo Yao Li Xue Bao; 1994 Jan; 15(1):36-8. PubMed ID: 8010082.
    Abstract:
    Trans(+-)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl) cyclohexyl]-benzeneacetamide-methanesulfonate-hydrate (U-50 488H), a specific kappa-agonist, at 1-10 mumol.L-1 caused concentration-dependent reductions in the action potential duration at 50% and 90% of repolarization (APD50 and APD90) without modifying the resting potential (RP), the action potential amplitude (APA) and the maximal upstroke velocity (Vmax). The effects were attenuated by (-)-(1R,5R,9R)-5,9-diethyl-2-(3-furylmethyl)-2L-hydroxy-6,7-benzomorphan (M(r) 2266 BS, 1 mumol.L-1), a specific kappa-antagonist which itself had no effect on the action potentials of the ventricular papillary muscle of guinea pigs, indicating that U-50 488H at 1-10 mumol.L-1 acts via specific cardiac kappa-receptors. At 100 mumol.L-1, U-50 488H not only shortened APD50 and APD90, but also reduced RP, APA, and Vmax, which were not attenuated by Mr 2266 BS (1 mumol.L-1) suggesting that the effects of U-50 488H at 100 mumol.L-1 were probably nonspecific.
    [Abstract] [Full Text] [Related] [New Search]